Trial site
XCancer Omaha / Urology Cancer Center
- 8running trials
- 5closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Prostate cancer13 trials
- Colorectal cancer2 trials
- Cervical cancer1 trial
- Gastric and oesophageal cancer1 trial
- Glioblastoma1 trial
- Head and neck cancer1 trial
- Lung cancer1 trial
- Pancreatic cancer1 trial
- Sarcoma1 trial
- Phase
- Phase 35 trials
- Phase 13 trials
- Phase 22 trials
- Early phase 11 trial
- Phase 1/21 trial
- Phase 41 trial
- Status
- Active, not recruiting6 trials
- Completed4 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Janssen Research & Development, LLC2 trials
- 3B Pharmaceuticals GmbH1 trial
- Blue Earth Diagnostics1 trial
- Blue Earth Therapeutics Ltd1 trial
- Brigham and Women's Hospital1 trial
- and 7 more
Running trials
Recruiting
Recruiting
Active, not recruiting
177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate
Active, not recruiting
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Prostate cancer2 recruiting
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Glioblastoma1 recruiting
- Lung cancer1 recruiting
Closed trials
Recruiting
Completed
Terminated
A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours
Completed
Completed
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
Site data: ClinicalTrials.govUpdated 12 Nov 2026